Buy
Average AnalystBuy
Top AnalystSlightly Bearish
Stock Target AdvisorStrong Buy
Average UserUSD 25.33
+1.18 (+4.89)%
USD 4.22B
0.02B
USD 23.25(-8.20%)
Symbol | Name | Exchange | HIMS's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
Global X Telemedicine & D.. | LSE | 4.49 % | 0.68 % | +0.04 (+0.56%) | USD3.92M |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.